Drug search by name

Olumiant and Skin cancer

Result of checking the interaction of drug Olumiant and disease Skin cancer for safety when used together.

Check result:

Olumiant <> Skin cancer

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Non-melanoma skin cancers (NMSCs) have been reported in patients treated with baricitinib. Consider the risks and benefits of baricitinib treatment prior to initiating therapy in patients with a known malignancy other than a successfully treated non-melanoma skin cancer (NMSC) or when considering continuing treatment in patients who develop a malignancy. Periodic skin examination is recommended for patients who are at increased risk for skin cancer. Exercise caution when using this agent in patients at increased risk.

Olumiant

Generic Name: baricitinib

Brand Name: Olumiant

Synonyms: n.a.

What is Olumiant?